Back to top

Ariad Pharmaceuticals (ARIA) Shares March Higher, Can It Continue?
September 30, 2016

Read MoreHide Full Article

Ariad Pharmaceuticals Inc. has been on the move lately as the stock has risen by 34.5% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on ARIA is moving in the right direction. In fact, the stock currently has a Zacks Rank #1 (Strong Buy), suggesting that the recent run could certainly continue for this in-focus company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>




Normally $25 each - click below to receive one report FREE:



More from Zacks Tale of the Tape

You May Like